glycemic control

CE: Diabetes: Setting the stride to improve glycemic control
CE: Diabetes: Setting the stride to improve glycemic control
Update on Diabetes TherapyDespite evidence that optimal glycemic control can help reduce disease progression and complications, most patients do not achieve recommended treatment goals.
Four areas of unnecessary senior healthcare
Four areas of unnecessary senior healthcareTwo reports highlight areas of elderly care that healthcare systems and health plans should avoid.
Aggressive blood sugar control slows diabetic eye disease progressionNIH-funded study shows less diabetic retinopathy progression among those who underwent intensive glycemic control.
Patient navigators can benefit diabetes outcomesStudy seeks to determine whether significant improvement in glycemic control can be achieved when regular coaching is part of the process.
First “follow-on” insulin glargine product approved to treat diabetesFDA approved insulin glargine injection (Basaglar, Eli Lilly) to improve glycemic control in patients with diabetes mellitus.
Tight glycemic control can do more harm to elderly patientsA new study reveals that tight glycemic control might not be the best goal for older adults with diabetes and other comorbidities.
FDA approves combined drug to improve glycemic control in diabetes patientsThe first-in-class combined medication for improving glycemic control in adults with type 2 diabetes has been approved by FDA.
New data examines sustained glycemic control with exenatide once weekly vs. insulin glarginePost-hoc analysis found that, despite continued titration with insulin glargine, more diabetes patients achieved sustained glycemic control with exenatide once-weekly, according to data presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Vienna, Austria.
FDA approves empagliflozin tablets for type 2 diabetesFDA approved empagliflozin (Jardiance, Boehringer Ingelheim Pharmaceuticals and Eli Lilly and Company) tablets as an adjunct to diet and exercise to improve glycemic control, or blood glucose levels, in adults with type 2 diabetes. Jardiance is not for people with type 1 diabetes or for people with diabetic ketoacidosis (increased ketones in the blood or urine).